Clinical Trial Update: A Study of Ixekizumab in Participants With Active Psoriatic Arthritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for ixekizumab in active psoriatic arthritis; trial completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• Ixekizumab (ixekizumab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Psoriasis, Arthritic | Phase 3 | Status: COMPLETED | Results posted: 2016-10-27